Purpose: Bone metastasis from stomach cancer occurs only rarely and it is known to have a very poor prognosis. This study examined the clinical characteristics and prognosis of patients who were diagnosed with stomach cancer and bone metastasis. Materials and Methods: The subjects were 19 patients who were diagnosed with stomach cancer at Hanyang University Medical Center from June 1992 to August 2010 and they also had bone metastasis. The survival rate according to many clinicopathologic factors was retrospectively analyzed. Results: 11 patients out of 18 patients (61%) who received an operation were in stage IV and the most common bone metastasis location was the spine. Bone scintigraphy was mostly used for diagnosing bone metastasis and PET-CT and magnetic resonance imaging were used singly or together. The serum alkaline phosphatase at the time of diagnosis had increased in 12 cases and there were clinical symptoms (bone pain) in 16 cases. Treatment was given to 14 cases and it was mostly radiotherapy. There were 2 cases of discovering bone metastasis at the time of diagnosing stomach cancer. The interval after operation to the time of diagnosing bone metastasis for the 18 cases that received a stomach cancer operation was on average 14.9±17.3 months and the period until death after the diagnosis of bone metastasis was on average 3.8±2.6 months. As a result of univariate survival rate analysis, the group that was treated for bone metastasis had a significantly better survival period when the bone metastasis was singular rather than multiple, as compared to the non-treatment group, yet both factors were not independent prognosis factors on multivariate survival analysis. Conclusions: An examination to confirm the status of bone metastasis when conducting a radio-tracer test after the initial diagnosis and also after an operation is needed for stomach cancer patients, and bone scintigraphy is the most helpfully modality. Making the diagnosis at the early stage and suitable treatments are expected to enhance the survival rate and improve the quality of life even for the patients with bone metastasis.
Introduction
The proportion of gastric cancer patients among the annually registered cancer patients in Korea is as high as approximately 20%. (1) It is very important to assess the presence or absence of metastasis to establish the treatment plans for gastric cancer, which occurs at such a high rate, and to predict the prognosis. Gastric cancer generally metastasizes to the peritoneal membrane, liver, lymph nodes, etc., and it may metastasize to the spleen, adrenalin, ovary, lung, brain and skin.
Bone metastasis generally occurs in patients with prostate cancer, breast cancer and lung cancer, and bone metastasis in gastric cancer patients has been shown to be very rare.(2-4) Bone metastasis is usually associated with disseminated vascular coagulation, hemolytic anemia and other hematological complications, and the prognosis is very poor.(5) The diverse incidence and prognosis of bone metastasis from gastric cancer have been reported in numerous studies, but this has not been sufficiently established in Korea.
Therefore, we conducted this study to examine the clinical characteristics of the patients diagnosed with gastric cancer by gastroscopy as well as histological tests, and these patients had bone metastasis detected simultaneously or later, and we also wanted to assess their prognosis.
the association with lung metastasis and brain metastasis were examined. In addition, by measuring the serum alkaline phosphatase (ALP) value, the changes of the ALP value in patients with bone metastasis was examined (Table 1) , and the difference of the mortality rate according to with or without treatments for bone metastasis was analyzed, as well as the treatment methods SPSS 13.0 (statistical Package for Social Science version 13.0, SPSS Inc., Chicago, IL, USA) was used for the data analysis, the survival rate was obtained by the Kaplan-Meier method and the significance of the No. = number; yr = year; TNM = tumor node metastasis; WEL = well differentiated adeno carcinoma; MOD = moderated differentiated adenocarcinoma; POR = poorly diff erentiated adenocarcinoma; SIG = signet ring cell carcinoma; MUC = mucinous carcinoma. 
Clinicopathological characteristics of bone metastasis
The area of bone metastasis was in the order of the vertebrae (17 cases, 89%), the costa (12 cases, 63%), the lower extremities (2 cases, 10 %), the scapula (2 cases, 10%) and the upper extremities (1 case, 5%). In regard to the diagnosis of bone metastasis lesions, there were 9 patients diagnosed by bone scintigraphy alone, 3 patients were diagnosed by using only positron emission tomography- 9 months, range: 0 ~73 months). The period from the diagnosis of bone metastasis to death was on average 3.8±2.6 months (median value: 3 months, range: 1~9 months (Table 2) .
The survival period of the gastric cancer patients with bone metastasis
In regard to the average survival period according to gender, that for the males was 3.4±0.7 months, that for the females was 4.7±1.1 months and there was no significant difference (P=0.401).
Based on the age of 60 years, the survival rate of the 5 patients older than 60 years and the 14 patients older than 60 years was 4.6 ±0.8 months and 3.5±0.7 months, respectively, and a significant difference was not shown (P=0.620) ( No. = number; SD = standard deviation; yr = year.
was significantly higher (P=0.019). Nonetheless, on the multivariate analysis of the survival period, it was not an independent prognostic factor ( Table 3, performed bone scintigraphy on 234 gastric cancer patients, and based on the presence or absence of hot uptake lesions, the frequency and pattern of bone metastasis were inferred and reported.
According to this, there were 106 patients who showed hot uptake lesions, the estimated incidence of bone metastasis was 45.3% and an elevated serum ALP value was associated with bone metastasis.
In our study, similarly, among the 19 patients, the serum ALP value bone scintigraphy has shortcomings that it is difficult to diagnose bone metastasis from malignant tumors in the cases with a hot uptake lesion. Therefore, it is considered that for cases with a solitary hot uptake lesion detected by bone scintigraphy, together with accurate history taking for fracture and other past medical problems, the rate of a false diagnosis of bone metastasis from gastric cancer could be decreased by making an accurate differential diagnosis from infectious bone diseases, metabolic bone diseases and other benign diseases. In our study, for the cases that a solitary lesion were positive for bone pain. Clinically, the cause of the worst suffering of patients with bone metastasis is bone pain. Therefore, pain management for patients with bone pain is very important.
In regard to radiation therapy for such bone pain, Murai et al. (19) have reported that 68 patients with bone metastasis were classi- died within 4 months after the diagnosis of bone metastasis. In our study, similarly, the period from the diagnosis of bone metastasis to death was on average 3.8±2.6 months, and it was found that the prognosis was very poor.
In conclusion, the prognosis of bone metastasis caused by gastric cancer is very poor and the prognosis of patients may be worsened due to a delayed diagnosis. Hence, tests to assess for bone metastasis are required for gastric cancer patients at the time of the initial diagnosis and the postsurgical follow-up observation, and bone scintigraphy with its high sensitivity appears to be most useful. In such a manner, it is anticipated that the survival period as well as the quality of life may be improved with making a rapid diagnosis and by administering radiation therapy and other appropriate treatments. Studies with a large number of larger subjects are required to assess the effect ofimproving the survival period according to different treatment methods.
